Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study

Korenobu Hayama(Chiba Hokusou Hospital), Keizo Kato(Shinmatsudo Central General Hospital), Yasuhito Tanaka(Kumamoto University), Joji Tani(Kagawa University), Kazuhito Kawata(Hamamatsu University School of Medicine), Hisashi Hidaka(Kitasato University), Hidenori Toyoda(Ogaki Municipal Hospital), Makoto Chuma(Yokohama City University Medical Center), Nobuhiko Taniai(Nippon Medical School), Atsushi Hiraoka(Ehime Prefectural Central Hospital), Yoshihiro Furuichi(Tokai University), Naoto Kawabe(Fujita Health University), Hiroshi Yoshida(Jikei University School of Medicine), Akito Nozaki(Yokohama City University Medical Center), Yoshitaka Arase(Tokai University), Katsuhiko Iwakiri(Nippon Medical School), Toshifumi Tada(Himeji Red Cross Hospital), Akemi Tsutsui(Kagawa Prefectural Central Hospital), Toru Ishikawa(Saiseikai Niigata Daini Hospital), Hiroshi Hasegawa(Shibaura Institute of Technology), Tatehiro Kagawa(Tokai University), Masanori Atsukawa(Nippon Medical School), Haruki Uojima(National Center for Global Health and Medicine), Kentaro Matsuura(Nagoya City University), Asahiro Morishita(Kagawa University), Hironao Okubo(Juntendo University Nerima Hospital), Akihito Tsubota(Jikei University School of Medicine), Tsunamasa Watanabe(St. Marianna University School of Medicine), Koichi Takaguchi(Kagawa Prefectural Central Hospital), Motoh Iwasa(Mie University), Chisa Kondo(Nippon Medical School), Tatsuya Suzuki(St. Marianna University School of Medicine)
Hepatology Research
September 22, 2022
Cited by 9


Related Papers